Expanded access programmes
Published in Pharmaceutical Medicine • May 1, 2013
NobleIDNI0P57W79R56S49
Abstract
Extract Overview Expanded access programmes are a way of making a promising medicine available to patients with significant unmet need, before it has actually gained marketing authorization. Both FDA and EMA have very specific guidelines on the setting up and administration of expanded access progra...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!